BUMYST
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Dec 2025)
What this means for you
This application is over — abandoned 29 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98381399
- Mark type
- Stylized text
- Filed
- 29 Jan 2024
- Published for opposition
- 01 Oct 2024
- Abandoned
- 29 Dec 2025
- Attorney of record
- Michael Sweetman
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular agents for medical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
Owner
- Corstasis Therapeutics Inc., Henderson, NV, US
- Corstasis Therapeutics Inc., Henderson, NV, US
Prosecution history
- 29 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 1 GRANTED
- 26 May 2025 — SOU EXTENSION 1 FILED
- 02 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jun 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 30 Jun 2025 — NOTICE OF REVIVAL - E-MAILED
- 30 Jun 2025 — PETITION TO REVIVE-GRANTED
- 30 Jun 2025 — TEAS PETITION TO REVIVE RECEIVED
- 30 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION